---

---

meeting   tags : Therapeutics   

save search

---

Black Diamond Therapeutics Announces Presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
BDTX | $5.06 1.0% 0.79% 360K |

Health Technology

| Email alert Add to watchlist
meeting therapeutics

---

TScan Therapeutics Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Meeting
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
TCRX | News 3 d | $7.38 1.65% 1.76% 91K |

Professional, Scientific, and T...

| Email alert Add to watchlist
meeting therapeutics

---

SpringWorks Therapeutics Announces Abstracts Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2024-04-24 (Crawled : 17:00) - globenewswire.com
SWTX | $43.38 -1.41% -1.45% 500K |

Health Technology

| -1.41% | O: -0.05% H: 2.16% C: -1.36%
presentation for meeting therapeutics

---

BioXcel Therapeutics Announces Late-Breaking Abstract on Preliminary Findings from Phase 2 Investigator-Sponsored Trial of BXCL701 and KEYTRUDA® in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) Selected for Presentation at 2024 ASCO Annual Meeting
Published: 2024-04-24 (Crawled : 14:00) - globenewswire.com
BTAI | News | $2.71 -8.75% -10.0% 870K |

Health Technology

| -8.75% | O: 0.0% H: 0.67% C: -8.75%
bxcl701 keytruda presentation asco pancreatic for meeting trial therapeutics

---

Werewolf Therapeutics Announces WTX-124 Clinical Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2024-04-24 (Crawled : 14:00) - globenewswire.com
HOWL | $6.39 -0.78% -0.55% 82K |

Professional, Scientific, and T...

| -0.78% | O: -0.93% H: 4.23% C: 0.16%
wtx-124 presentation for meeting therapeutics

---

Capricor Therapeutics Announces Positive Type-B Meeting with FDA for CAP-1002 Program for Duchenne Muscular Dystrophy
Published: 2024-04-24 (Crawled : 13:00) - globenewswire.com
CAPR | $5.04 4.56% 4.37% 920K |

Health Technology

| 4.56% | O: 9.13% H: 7.41% C: -4.18%
cap-1002 fda positive program therapeutics duchenne type-b meeting

---

Werewolf Therapeutics Presents First Preclinical Data Highlighting IL-10 INDUKINE Molecules as a Potential Therapy for Inflammatory Bowel Disease (IBD) at AAI Annual Meeting
Published: 2024-04-23 (Crawled : 12:00) - globenewswire.com
HOWL | $6.39 -0.78% -0.55% 82K |

Professional, Scientific, and T...

| 6.5% | O: 2.17% H: 5.06% C: 5.06%
il-10 first disease preclinical for meeting therapeutics potential therapy

---

Omega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual Meeting
Published: 2024-04-23 (Crawled : 11:00) - globenewswire.com
OMGA | $2.33 -0.43% -0.21% 180K |

| -6.43% | O: -4.02% H: 6.28% C: -2.09%
cell preclinical meeting therapeutics therapy

---

TScan Therapeutics Announces Upcoming Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting
Published: 2024-04-22 (Crawled : 21:00) - globenewswire.com
TCRX | News 3 d | $7.38 1.65% 1.76% 91K |

Professional, Scientific, and T...

| 3.65% | O: 1.4% H: 4.57% C: 0.55%
cell meeting therapeutics therapy

---

CRISPR Therapeutics to Present Oral Presentation at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting
Published: 2024-04-22 (Crawled : 21:00) - globenewswire.com
CRSP | News 4 | $55.65 -1.35% -1.35% 790K |

Health Technology

| -0.02% | O: 0.49% H: 4.9% C: 0.86%
crispr presentation cell meeting therapeutics therapy

---

Fate Therapeutics Announces Presentation of FT819 Proof-of-Concept Data for B cell-mediated Autoimmune Diseases at ASGCT Annual Meeting
Published: 2024-04-22 (Crawled : 20:00) - globenewswire.com
FATE | News | $4.3 -5.29% -5.58% 1.7M |

Health Technology

| -10.04% | O: 0.21% H: 4.8% C: -5.22%
ft819 presentation for meeting therapeutics

---

Voyager Therapeutics to Present Broad Set of Translational Data Supporting IV-Delivered, CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting
Published: 2024-04-22 (Crawled : 20:00) - globenewswire.com
VYGR | News | $7.57 -1.05% -1.06% 310K |

Health Technology

| 0.0% | O: 0.4% H: 2.37% C: 0.66%
SGMO | News | $0.493 -5.36% -6.07% 1.2M |

Health Technology

| -3.92% | O: 1.96% H: 9.62% C: 0.0%
NBIX | News 4 | $138.97 -0.8% -0.85% 930K |

Health Technology

| 3.97% | O: 5.49% H: 2.84% C: -0.65%
trials meeting set therapeutics therapy

---

Poseida Therapeutics Announces Strong Lineup of Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
PSTX | $2.07 -4.17% -4.6% 460K |

Health Technology

| 1.47% | O: 0.25% H: 0.0% C: 0.0%
cell meeting therapeutics therapy

---

TG Therapeutics Announces Additional Data Presentations for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting
Published: 2024-04-18 (Crawled : 12:00) - globenewswire.com
TGTX | $13.98 -1.9% -1.86% 2.4M |

Health Technology

| -0.5% | O: -0.43% H: 4.57% C: 0.0%
briumvi neurology sclerosis for meeting therapeutics

---

Alterity Therapeutics Parkinson’s Disease and Multiple System Atrophy Data Featured at the American Academy of Neurology (AAN) 2024 Annual Meeting
Published: 2024-04-17 (Crawled : 01:00) - alteritytherapeutics.com
ATHE | $2.33 9.39% 8.58% 170K |

Health Technology

| 13.66% | O: 0.0% H: 7.32% C: -1.95%
disease neurology system meeting parkinson’s therapeutics

---

Zevra Therapeutics Presents New Data on the Long-Term Safety and Efficacy of Arimoclomol as a Treatment for Niemann-Pick Disease Type C at the SIMD 45th Annual Meeting
Published: 2024-04-15 (Crawled : 21:00) - globenewswire.com
ZVRA | $4.56 -0.44% -0.22% 160K |

n/a

| -4.7% | O: 1.15% H: 1.03% C: -1.45%
disease treatment for meeting therapeutics

---

TG Therapeutics Announces Presentation of Data for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting
Published: 2024-04-15 (Crawled : 12:00) - globenewswire.com
TGTX | $13.98 -1.9% -1.86% 2.4M |

Health Technology

| -5.09% | O: -3.94% H: 3.0% C: -0.57%
briumvi neurology presentation sclerosis for meeting therapeutics

---

Axsome Therapeutics Highlights Innovative Neuroscience Portfolio at the American Academy of Neurology (AAN) 2024 Annual Meeting
Published: 2024-04-15 (Crawled : 11:00) - globenewswire.com
AXSM | $71.17 -2.61% -2.6% 580K |

Health Technology

| 0.06% | O: -3.37% H: 0.83% C: -0.76%
neurology meeting therapeutics

---

Aquestive Therapeutics to Present Crossover Study Data for Libervant™ (diazepam) Buccal Film at 76th Annual Meeting of the American Academy of Neurology
Published: 2024-04-12 (Crawled : 20:00) - globenewswire.com
AQST | $3.9 -8.88% -9.6% 2M |

Health Technology

| Email alert Add to watchlist
neurology for meeting therapeutics study

---

Aprea Therapeutics Announces Presentations on its Next Generation WEE1 Inhibitor, APR-1051, and A Novel Macrocyclic ATR Inhibitor, ATRN-119, at AACR Annual Meeting 2024
Published: 2024-04-10 (Crawled : 16:00) - globenewswire.com
APRE | $5.17 -3.72% 6.3% 6.3K |

Health Technology

| -14.4% | O: -2.14% H: 4.91% C: 4.91%
apr-1051 meeting therapeutics

---

Gainers vs Losers

62%

38%

Top 10 Gainers

CSSE 4 | $0.4253 179.25% 64.77% 210M |

Consumer Services

BOF | $2.08 77.78% 41.21% 110M |

ILAG | $0.54 12.27% 40.62% 3.7M |

LICN | $0.999 78.39% 40.49% 15M |

AMST | $3.4 70.0% 39.58% 70M |

Technology Services

MTC | $3.6 60.71% 38.04% 9.1M |

Technology Services

WIMI | $1.15 58.53% 36.92% 19M |

Technology Services

AIH | $0.458 14.5% 30.92% 91K |

Health Services

WHLM | $6.25 35.87% 28.46% 700K |

Commercial Services

MULN | News | $3.77 38.1% 27.78% 13M |

Information

---

Your saved searches

---